These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 19530505)

  • 1. Immunologic and genetic links between spondylarthropathies and inflammatory bowel diseases.
    Faustini F; Zoli A; Ferraccioli GF
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():1-9. PubMed ID: 19530505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.
    Turkcapar N; Toruner M; Soykan I; Aydintug OT; Cetinkaya H; Duzgun N; Ozden A; Duman M
    Rheumatol Int; 2006 May; 26(7):663-8. PubMed ID: 16136311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies].
    Mielants H; Veys EM
    Verh K Acad Geneeskd Belg; 1996; 58(2):93-116. PubMed ID: 8768479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enteropathic spondylarthritis in chronic inflammatory bowel diseases: prevalence, manifestation pattern and HLA association].
    Protzer U; Duchmann R; Höhler T; Hitzler W; Ewe K; Wanitschke R; Meyer zum Büschenfelde KH; Märker-Hermann E
    Med Klin (Munich); 1996 Jun; 91(6):330-5. PubMed ID: 8767304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint involvement associated with inflammatory bowel disease.
    De Vos M
    Dig Dis; 2009; 27(4):511-5. PubMed ID: 19897967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies.
    Fantini MC; Pallone F; Monteleone G
    World J Gastroenterol; 2009 May; 15(20):2472-8. PubMed ID: 19468997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment.
    Fragoulis GE; Liava C; Daoussis D; Akriviadis E; Garyfallos A; Dimitroulas T
    World J Gastroenterol; 2019 May; 25(18):2162-2176. PubMed ID: 31143068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteropathic spondyloarthropathy: a common genetic background with inflammatory bowel disease?
    Colombo E; Latiano A; Palmieri O; Bossa F; Andriulli A; Annese V
    World J Gastroenterol; 2009 May; 15(20):2456-62. PubMed ID: 19468994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The joint-gut axis in inflammatory bowel diseases.
    Brakenhoff LK; van der Heijde DM; Hommes DW; Huizinga TW; Fidder HH
    J Crohns Colitis; 2010 Sep; 4(3):257-68. PubMed ID: 21122514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate and adaptive immunity in inflammatory bowel disease.
    Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
    Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis.
    Breban M; Tap J; Leboime A; Said-Nahal R; Langella P; Chiocchia G; Furet JP; Sokol H
    Ann Rheum Dis; 2017 Sep; 76(9):1614-1622. PubMed ID: 28606969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ankylosing Spondylitis and Axial Spondyloarthritis in Patients With Long-term Inflammatory Bowel Disease: Results From 20 Years of Follow-up in the IBSEN Study.
    Ossum AM; Palm Ø; Lunder AK; Cvancarova M; Banitalebi H; Negård A; Høie O; Henriksen M; Moum BA; Høivik ML;
    J Crohns Colitis; 2018 Jan; 12(1):96-104. PubMed ID: 28961700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence from genetics for a role of autophagy and innate immunity in IBD pathogenesis.
    Parkes M
    Dig Dis; 2012; 30(4):330-3. PubMed ID: 22796792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ankylosing spondylitis and bowel disease.
    Rudwaleit M; Baeten D
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):451-71. PubMed ID: 16777576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seronegative spondyloarthropathy-associated inflammatory bowel disease.
    Wang CR; Tsai HW
    World J Gastroenterol; 2023 Jan; 29(3):450-468. PubMed ID: 36688014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intimate relationship between gut and joint in spondyloarthropathies.
    Jacques P; Mielants H; Coppieters K; De Vos M; Elewaut D
    Curr Opin Rheumatol; 2007 Jul; 19(4):353-7. PubMed ID: 17551365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammatory bowel diseases: an immunological approach].
    Sepúlveda SE; Beltrán CJ; Peralta A; Rivas P; Rojas N; Figueroa C; Quera R; Hermoso MA
    Rev Med Chil; 2008 Mar; 136(3):367-75. PubMed ID: 18575665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of bone strength in HLA-B27 transgenic rats is characterized by a high bone turnover and is mainly osteoclast-driven.
    Rauner M; Thiele S; Fert I; Araujo LM; Layh-Schmitt G; Colbert RA; Hofbauer C; Bernhardt R; Bürki A; Schwiedrzik J; Zysset PK; Pietschmann P; Taurog JD; Breban M; Hofbauer LC
    Bone; 2015 Jun; 75():183-91. PubMed ID: 25746795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2273-8. PubMed ID: 8835561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Putative Pathobionts in HLA-B27-Associated Spondyloarthropathy.
    Gill T; Rosenbaum JT
    Front Immunol; 2020; 11():586494. PubMed ID: 33537028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.